I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Real World Patient Eligibility for Second Line Lurbinectedi..:
Rittberg, Rebekah
;
Leung, Bonnie
;
Al-Hashami, Zamzam
.
Current Oncology. 29 (2022) 12 - p. 9744-9752 , 2022
Link:
https://doi.org/10.3390/curroncol29120765
RT Journal T1
Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care Utilization
UL https://suche.suub.uni-bremen.de/peid=cr-10.3390_curroncol29120765&Exemplar=1&LAN=DE A1 Rittberg, Rebekah A1 Leung, Bonnie A1 Al-Hashami, Zamzam A1 Ho, Cheryl PB MDPI AG YR 2022 SN 1718-7729 JF Current Oncology VO 29 IS 12 SP 9744 OP 9752 LK http://dx.doi.org/https://doi.org/10.3390/curroncol29120765 DO https://doi.org/10.3390/curroncol29120765 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)